Frontlight ResearchEarly access
Trial site
The First Medical Center of Chinese PLA General Hospital
- 9running trials
- 2closed trials
The trials here
What the 11 trials at this site are about, from their registry records.
- Conditions
- Type 2 diabetes2 trials
- ANCA-associated vasculitis1 trial
- Antiphospholipid syndrome1 trial
- Chronic kidney disease1 trial
- Coronary artery disease1 trial
- Lung cancer1 trial
- Lupus (SLE)1 trial
- Metastatic breast cancer1 trial
- Migraine1 trial
- Neuromyelitis optica (NMOSD)1 trial
- Ovarian cancer1 trial
- Prostate cancer1 trial
- and 3 more
- Phase
- Phase 34 trials
- Phase 42 trials
- Phase 11 trial
- Phase 21 trial
- Phase 2/31 trial
- Status
- Recruiting4 trials
- Not yet recruiting3 trials
- Active, not recruiting2 trials
- Completed2 trials
- Lead sponsor
- Chinese PLA General Hospital2 trials
- Akeso1 trial
- China Immunotech (Beijing) Biotechnology Co., Ltd.1 trial
- Gilead Sciences1 trial
- Junjie Yang1 trial
- and 5 more
Running trials
Not yet recruiting
Not yet recruiting
Efficacy and Safety of Lenalidomide in Patients With IgG4-Related Disease
Recruiting
Therapy in the Acute Phase of NMOSD: A Multicenter Prospective Real-World Study
Recruiting
SGLT2 Inhibitors on Coronary Atherosclerosis Progression Via Perivascular Adipose Tissue in Diabetes
Not yet recruiting
Cofrogliptin and Linagliptin as add-on Therapy to Insulin in Type 2 Diabetes
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Type 2 diabetes2 recruiting
- ANCA-associated vasculitis1 recruiting
- Antiphospholipid syndrome1 recruiting
- Coronary artery disease1 recruiting
- Lung cancer1 recruiting
- Lupus (SLE)1 recruiting
- Neuromyelitis optica (NMOSD)1 recruiting
- Prostate cancer1 recruiting
- Rheumatoid arthritis1 recruiting
- Systemic sclerosis (scleroderma)1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 17 Nov 2026